Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 75 of 110 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/10/17
End: 09/30/18
Due: 09/30/19
Phase: N/A
Priority: Normal
Start: 12/15/17
End: 07/15/23
Due: 07/15/24
Phase: N/A
Priority: Normal
Start: 05/12/14
End: 10/10/20
Due: 10/10/21
Phase: N/A
Priority: Normal
Start: 03/01/23
End: 06/30/23
Due: 06/30/24
Phase: N/A
Priority: Normal
Start: 05/01/21
End: 02/01/22
Due: 02/01/23
Phase: N/A
Priority: Normal
Start: 07/09/19
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 09/08/20
End: 09/08/21
Due: 09/08/22
Phase: N/A
Priority: Normal
Start: 07/31/14
End: 03/31/19
Due: 03/31/20
Phase: N/A
Priority: Normal
Start: 10/21/19
End: 12/31/21
Due: 12/31/22
Phase: N/A
Priority: Normal
Start: 01/31/12
End: 02/28/14
Due: 02/28/15
Donor Regulatory T-cells for cGVHD in Patients Who do Not Obtain Complete Remission With Ruxolitinib
Phase: N/A
Priority: Normal
Start: 03/24/22
End: 02/15/26
Due: 02/15/27
Phase: N/A
Priority: Normal
Start: 10/01/18
End: 12/01/21
Due: 12/01/22
Phase: N/A
Priority: Normal
Start: 10/31/10
End: 08/31/14
Due: 08/31/15
Phase: N/A
Priority: Normal
Start: 01/16/18
End: 06/30/21
Due: 06/30/22
Phase: N/A
Priority: Normal
Start: 11/25/13
End: 11/05/15
Due: 11/05/16
Phase: N/A
Priority: Normal
Start: 12/01/24
End: 03/31/26
Due: 03/31/27
Phase: N/A
Priority: Normal
Start: 10/01/24
End: 10/01/28
Due: 10/01/29
Phase: N/A
Priority: Normal
Start: 04/04/19
End: 07/15/21
Due: 07/15/22
Phase: N/A
Priority: Normal
Start: 02/01/23
End: 10/31/24
Due: 10/31/25
Phase: N/A
Priority: Normal
Start: 12/30/24
End: 12/30/28
Due: 12/30/29
Phase: N/A
Priority: Normal
Start: 10/31/24
End: 06/30/27
Due: 06/30/28
Phase: N/A
Priority: Normal
Start: 01/01/22
End: 09/01/22
Due: 09/01/23
Phase: N/A
Priority: Normal
Start: 10/31/12
End: 10/31/13
Due: 10/31/14
Phase: N/A
Priority: Normal
Start: 04/12/23
End: 12/30/25
Due: 12/30/26
Phase: N/A
Priority: Normal
Start: 10/15/19
End: 06/15/20
Due: 06/15/21